We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Amarin Appoints Medpace as CRO for two Phase 3 Cardiovascular Trials

News   Oct 20, 2009

 
Amarin Appoints Medpace as CRO for two Phase 3 Cardiovascular Trials
 
 
Advertisement
 

RELATED ARTICLES

Biomarkers Could Be Used in Quick COVID-19 Blood Screening Strategy

News

A new study suggests that COVID-19 affects the human body’s blood concentration levels of specific metabolites. Three metabolites identified in the study could act as biomarkers and hold potential to be measured through an inexpensive blood test to quickly screen patients for the disease.

READ MORE

Spanish Study Explores Vitamin D Deficiency in COVID-19 Patients

News

Over 80 percent of 200 COVID-19 patients in a hospital in Spain have vitamin D deficiency, according to a new study.

READ MORE

Trial Will Investigate if Anti-Nausea Drug Can Alleviate Hallucinations in People With Parkinson's

News

Phase 2 clinical trial will explore if the drug ondansetron is safe and effective against hallucinations in patients with Parkinson's disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE